DSpace

Digital.CSIC > Biología y Biomedicina > Centro Nacional de Biotecnología (CNB) > (CNB) Artículos >

Share

EndNote

Impact

Open Access item The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

Authors:Lara-Pezzi, Enrique
Gómez Gaviro, María Victoria
Gálvez, Beatriz G.
Mira, Emilia
Iñiguez, Miguel Angel
Fresno, Manuel
Martínez-Alonso, Carlos
Arroyo, Alicia G.
López Cabrera, Manuel
Issue Date:Dec-2002
Publisher:American Society for Clinical Investigation
Citation:The Journal of Clinical Investigation, 110,pp.1831–1838, (2002)
Abstract:Hepatocellular carcinoma is strongly associated with chronic infection by the hepatitis B virus (HBV) and has poor prognosis due to intrahepatic metastasis. HBx is often the only HBV protein detected in hepatic tumor cells; however, its contribution to tumor invasion and metastasis has not been established so far. In this work, we show that HBx enhances tumor cell invasion, both in vivo and in vitro. The increased invasive capacity induced by HBx is mediated by an upregulation of membrane-type 1 matrix metalloproteinase (MT1-MMP) expression, which in turn activates matrix metalloproteinase-2. Induction of both MT1-MMP expression and cell invasion by HBx is dependent on cyclooxygenase-2 (COX-2) activity. In addition, HBx upregulates the expression of COX-2, which is mediated by the transcriptional activation of the COX-2 gene promoter in a nuclear factor of activated T cell–dependent (NF-AT–dependent) manner. These results demonstrate the ability of HBx to promote tumor cell invasion by a mechanism involving the upregulation of MT1-MMP and COX-2 and provide new insights into the mechanism of action of this viral protein and its involvement in tumor metastasis and recurrence of hepatocellular carcinoma.
URI:http://hdl.handle.net/10261/3592
ISSN:0021-9738
???metadata.dc.identifier.doi???:10.1172/JCI200215887.
Appears in Collections:(CNB) Artículos

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.